Literature DB >> 2750647

Prognostic significance of the signal-averaged ECG depends on the time of recording in the postinfarction period.

N el-Sherif1, S N Ursell, S Bekheit, J Fontaine, G Turitto, R Henkin, E B Caref.   

Abstract

Serial recordings of the signal-averaged ECG and the 24-hour ambulatory ECG were obtained from 156 patients with acute myocardial infarction up to 5 days (phase 1), 6 to 30 days (phase 2), and 31 to 60 days (phase 3) after the infarction. Left ventricular ejection fraction by radionuclide ventriculography was also determined in phase 2. The signal-averaged ECG was abnormal during one or more of the three phases in 51 patients (31%). In 35 of these patients (69%) the recording changed category between normal and abnormal with the highest prevalence of abnormal recording occurring during phase 2. Eight patients had ventricular tachycardia/ventricular fibrillation in the first 48 hours after myocardial infarction. The signal-averaged ECG was abnormal in only one of these patients. Twelve patients had late arrhythmic events during the first year of follow-up (four sudden deaths and eight instances of documented ventricular tachycardia or ventricular fibrillation). Nine of the 12 patients had an abnormal signal-averaged ECG in phase 2 and four of these nine had a normal recording in phase 1. Five patients had a transient abnormal signal-averaged ECG in phase 1, whereas six patients had an abnormal recording only in phase 3. None of these 11 patients had an arrhythmic event. Stepwise logistic regression showed that an abnormal signal-averaged ECG in phase 2 has the most significant relation to late arrhythmic events. Both an abnormal signal-averaged ECG and a left ventricular ejection fraction less than 40%, but not complex ventricular arrhythmias, were independent significant risk factors for late arrhythmic events.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2750647     DOI: 10.1016/0002-8703(89)90183-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

Review 1.  The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia.

Authors:  J A Gomes
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

2.  Significance of perfusion of the infarct related coronary artery for susceptibility to ventricular tachyarrhythmias in patients with previous myocardial infarction.

Authors:  H V Huikuri; M J Koistinen; K E Airaksinen; M J Ikäheimo
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

3.  Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival.

Authors:  A A Armoundas; D S Rosenbaum; J N Ruskin; H Garan; R J Cohen
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

Review 4.  Risk stratification after myocardial infarction: role of electrical instability, ischemia, and left ventricular function.

Authors:  A Bayés-de-Luna; X Viñolas; J Guindo; A Bayés-Genis
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

5.  Effects of early losartan therapy on ventricular late potentials in acute myocardial infarction.

Authors:  Dae-Hyeok Kim; Woong-Gil Choi; Jun Kwan; Keum-Soo Park; Woo-Hyung Lee
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

6.  Developing barbed microtip-based electrode arrays for biopotential measurement.

Authors:  Li-Sheng Hsu; Shu-Wei Tung; Che-Hsi Kuo; Yao-Joe Yang
Journal:  Sensors (Basel)       Date:  2014-07-10       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.